331 related articles for article (PubMed ID: 35549675)
21. Genotypic and phenotypic insights into virulence factors of nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria (2011-2022).
Strateva T; Trifonova A; Stratev A; Peykov S
Acta Microbiol Immunol Hung; 2023 Sep; 70(3):220-230. PubMed ID: 37405903
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.
Pompilio A; Pomponio S; Crocetta V; Gherardi G; Verginelli F; Fiscarelli E; Dicuonzo G; Savini V; D'Antonio D; Di Bonaventura G
BMC Microbiol; 2011 Jul; 11():159. PubMed ID: 21729271
[TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of phenotypical and genotypical methods for the identification and typing of Stenotrophomonas maltophilia isolated from a pharmaceutical facility.
de Miranda RVDSL; Monteiro GM; da Costa LV; Dos Santos MCS; Dos Reis CMF; Braga LMPDS; Forsythe SJ; Villas Bôas MHS; Brandão MLL
J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37838475
[TBL] [Abstract][Full Text] [Related]
25. Clinical associations with carriage of pulmonary
Watson L; Priestley L; Chapman SJ; Andersson MI; Jeffery K; Flight WG
J R Coll Physicians Edinb; 2022 Mar; 52(1):14-19. PubMed ID: 36146962
[TBL] [Abstract][Full Text] [Related]
26.
Li K; Yu K; Huang Z; Liu X; Mei L; Ren X; Bai X; Gao H; Sun Z; Liu X; Wang D
Front Cell Infect Microbiol; 2023; 13():1325379. PubMed ID: 38268792
[TBL] [Abstract][Full Text] [Related]
27. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.
Anderson SW; Stapp JR; Burns JL; Qin X
J Clin Microbiol; 2007 Feb; 45(2):529-35. PubMed ID: 17135443
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
29. Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance.
Vidigal PG; Dittmer S; Steinmann E; Buer J; Rath PM; Steinmann J
Int J Med Microbiol; 2014 Jul; 304(5-6):613-9. PubMed ID: 24836944
[TBL] [Abstract][Full Text] [Related]
30. Taxonogenomics reveal multiple novel genomospecies associated with clinical isolates of Stenotrophomonas maltophilia.
Patil PP; Kumar S; Midha S; Gautam V; Patil PB
Microb Genom; 2018 Aug; 4(8):. PubMed ID: 30084764
[TBL] [Abstract][Full Text] [Related]
31. A guide to
Bhaumik R; Aungkur NZ; Anderson GG
Front Cell Infect Microbiol; 2023; 13():1322853. PubMed ID: 38274738
[TBL] [Abstract][Full Text] [Related]
32. Cystic Fibrosis-Associated Stenotrophomonas maltophilia Strain-Specific Adaptations and Responses to pH.
Gallagher T; Phan J; Oliver A; Chase AB; England WE; Wandro S; Hendrickson C; Riedel SF; Whiteson K
J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30642989
[TBL] [Abstract][Full Text] [Related]
33. The Toxin-Antitoxin Systems of the Opportunistic Pathogen
Klimkaitė L; Armalytė J; Skerniškytė J; Sužiedėlienė E
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019620
[No Abstract] [Full Text] [Related]
34. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
Wu K; Yau YC; Matukas L; Waters V
Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
[TBL] [Abstract][Full Text] [Related]
35. Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.
Nas MY; Gabell J; Cianciotto NP
mBio; 2021 Jun; 12(3):e0150221. PubMed ID: 34182776
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
37. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
38. Stenotrophomonas maltophilia drug resistance.
Sanchez MB; Hernandez A; Martinez JL
Future Microbiol; 2009 Aug; 4(6):655-60. PubMed ID: 19659422
[TBL] [Abstract][Full Text] [Related]
39. Advances in the Microbiology of Stenotrophomonas maltophilia.
Brooke JS
Clin Microbiol Rev; 2021 Jun; 34(3):e0003019. PubMed ID: 34043457
[TBL] [Abstract][Full Text] [Related]
40. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity.
Flores-Treviño S; Gutiérrez-Ferman JL; Morfín-Otero R; Rodríguez-Noriega E; Estrada-Rivadeneyra D; Rivas-Morales C; Llaca-Díaz JM; Camacho-Ortíz A; Mendoza-Olazarán S; Garza-González E
J Med Microbiol; 2014 Nov; 63(Pt 11):1524-1530. PubMed ID: 25165124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
